124 related articles for article (PubMed ID: 9846574)
21. Ameliorating effect of anti-Fas ligand MAb on wasting disease in murine model of chronic colitis.
Dan N; Kanai T; Totsuka T; Iiyama R; Yamazaki M; Sawada T; Miyata T; Yagita H; Okumura K; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G754-60. PubMed ID: 12969829
[TBL] [Abstract][Full Text] [Related]
22. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
Arnold R; Seifert M; Asadullah K; Volk HD
J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
[TBL] [Abstract][Full Text] [Related]
23. The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death.
Dai Z; Arakelov A; Wagener M; Konieczny BT; Lakkis FG
J Immunol; 1999 Sep; 163(6):3131-7. PubMed ID: 10477579
[TBL] [Abstract][Full Text] [Related]
24. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
Nagai H; Kubo M; Abe R; Yamamoto M; Nohara K
Int Immunopharmacol; 2006 Feb; 6(2):279-86. PubMed ID: 16399633
[TBL] [Abstract][Full Text] [Related]
25. Role of Fas/Fas ligand-mediated apoptosis in murine contact hypersensitivity.
Xu B; Bulfone-Paus S; Aoyama K; Yu S; Huang P; Morimoto K; Matsushita T; Takeuchi T
Int Immunopharmacol; 2003 Jul; 3(7):927-38. PubMed ID: 12810350
[TBL] [Abstract][Full Text] [Related]
26. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes.
Sobek V; Balkow S; Körner H; Simon MM
Eur J Immunol; 2002 Sep; 32(9):2490-9. PubMed ID: 12207333
[TBL] [Abstract][Full Text] [Related]
27. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R
Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826
[TBL] [Abstract][Full Text] [Related]
28. Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis.
Dick AD; Siepmann K; Dees C; Duncan L; Broderick C; Liversidge J; Forrester JV
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2258-67. PubMed ID: 10476791
[TBL] [Abstract][Full Text] [Related]
29. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.
Muppidi JR; Siegel RM
Nat Immunol; 2004 Feb; 5(2):182-9. PubMed ID: 14745445
[TBL] [Abstract][Full Text] [Related]
30. A death factor--the other side of the coin.
Nagata S
Behring Inst Mitt; 1996 Oct; (97):1-11. PubMed ID: 8950463
[TBL] [Abstract][Full Text] [Related]
31. Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.
Rabinowich H; Reichert TE; Kashii Y; Gastman BR; Bell MC; Whiteside TL
J Clin Invest; 1998 Jun; 101(11):2579-88. PubMed ID: 9616229
[TBL] [Abstract][Full Text] [Related]
32. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand.
Miwa K; Asano M; Horai R; Iwakura Y; Nagata S; Suda T
Nat Med; 1998 Nov; 4(11):1287-92. PubMed ID: 9809553
[TBL] [Abstract][Full Text] [Related]
33. Exposure to a metabolite of the environmental toxicant, trichloroethylene, attenuates CD4+ T cell activation-induced cell death by metalloproteinase-dependent FasL shedding.
Blossom SJ; Gilbert KM
Toxicol Sci; 2006 Jul; 92(1):103-14. PubMed ID: 16641322
[TBL] [Abstract][Full Text] [Related]
34. Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back.
Walker PR; Saas P; Dietrich PY
J Immunol; 1997 May; 158(10):4521-4. PubMed ID: 9144461
[TBL] [Abstract][Full Text] [Related]
35. Elimination of activated but not resting primary human CD4+ and CD8+ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells.
Hoves S; Krause SW; Herfarth H; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
Immunobiology; 2004; 208(5):463-75. PubMed ID: 15124861
[TBL] [Abstract][Full Text] [Related]
36. Fas and FasL in the homeostatic regulation of immune responses.
Lynch DH; Ramsdell F; Alderson MR
Immunol Today; 1995 Dec; 16(12):569-74. PubMed ID: 8579749
[TBL] [Abstract][Full Text] [Related]
37. Allergen immunotherapy decreases specific allergen-induced expression of Fas and FasL on CD4+ and CD8+ cells.
Zak-Nejmark T; Nowak IA; Malolepszy J
J Investig Allergol Clin Immunol; 2005; 15(1):63-8. PubMed ID: 15864885
[TBL] [Abstract][Full Text] [Related]
38. The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells.
Riccio M; Carnevale G; Cardinale V; Gibellini L; De Biasi S; Pisciotta A; Carpino G; Gentile R; Berloco PB; Brunelli R; Bastianelli C; Napoletano C; Cantafora A; Cossarizza A; Gaudio E; Alvaro D; De Pol A
J Hepatol; 2014 Nov; 61(5):1097-105. PubMed ID: 24953023
[TBL] [Abstract][Full Text] [Related]
39. CD8+ T cells promote inflammation and apoptosis in the liver after sepsis: role of Fas-FasL.
Wesche-Soldato DE; Chung CS; Gregory SH; Salazar-Mather TP; Ayala CA; Ayala A
Am J Pathol; 2007 Jul; 171(1):87-96. PubMed ID: 17591956
[TBL] [Abstract][Full Text] [Related]
40. Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10.
Lundy SK; Boros DL
Infect Immun; 2002 Feb; 70(2):812-9. PubMed ID: 11796615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
